|
SMEK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.343500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.463300E-03 |
| Normal-vs-Stage2 |
9.141800E-02 |
| Normal-vs-Stage3 |
2.003600E-01 |
| Normal-vs-Stage4 |
6.005000E-01 |
| Stage1-vs-Stage2 |
7.801400E-01 |
| Stage1-vs-Stage3 |
2.828800E-01 |
| Stage1-vs-Stage4 |
9.195800E-02 |
| Stage2-vs-Stage3 |
3.893400E-01 |
| Stage2-vs-Stage4 |
1.954440E-01 |
| Stage3-vs-Stage4 |
5.168600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.104010E-03 |
| Normal-vs-AfricanAmerican |
3.656100E-02 |
| Normal-vs-Asian |
3.843000E-01 |
| Caucasian-vs-AfricanAmerican |
1.96317999999751E-05 |
| Caucasian-vs-Asian |
8.134600E-01 |
| AfricanAmerican-vs-Asian |
1.388040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.430300E-02 |
| Normal-vs-Female |
1.375050E-03 |
| Male-vs-Female |
5.803700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.810600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.798400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.358200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.240400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.898200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.215180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.415600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.373600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.172200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.615000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.752000E-01 |
| Normal-vs-Grade 2 |
2.790000E-04 |
| Normal-vs-Grade 3 |
3.564300E-02 |
| Normal-vs-Grade 4 |
3.522400E-01 |
| Grade 1-vs-Grade 2 |
3.706200E-01 |
| Grade 1-vs-Grade 3 |
9.203800E-01 |
| Grade 1-vs-Grade 4 |
2.024400E-01 |
| Grade 2-vs-Grade 3 |
7.086400E-02 |
| Grade 2-vs-Grade 4 |
3.026300E-04 |
| Grade 3-vs-Grade 4 |
1.462310E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.63890020946178E-10 |
| Normal-vs-ccB subtype |
8.762600E-01 |
| ccA subtype-vs-ccB subtype |
7.09119996056273E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.007850E-02 |
| Normal-vs-N1 |
8.886800E-01 |
| N0-vs-N1 |
4.501600E-01 |
|
|
